Suggested Topics within your search.
Showing 41 - 60 results of 95 for search '"Cancer immunology"', query time: 0.09s Refine Results
  1. 41
    Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study

    Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcino... by Emiel A. De Jaeghere, Sandra Tuyaerts, An M. T. Van Nufel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Lien Lippens, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, Peter A. van Dam, Sandrine Aspeslagh, Alex De Caluwé, Eline Naert, Diether Lambrechts, An Hendrix, Olivier De Wever, Koen K. Van de Vijver, Frédéric Amant, Katrien Vandecasteele, Hannelore G. Denys

    Published 2024-12-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 42
    Nicotine promotes M2 macrophage polarization through α5-nAChR/SOX2/CSF-1 axis in lung adenocarcinoma

    Nicotine promotes M2 macrophage polarization through α5-nAChR/SOX2/CSF-1 axis in lung adenocarcinoma by Guiyu Kang, Hui Song, Lei Bo, Qi Liu, Qiang Li, Jingtan Li, Pan Pan, Jingting Wang, Yanfei Jia, Haiji Sun, Xiaoli Ma

    Published 2024-11-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 43
    Correction: Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study

    Correction: Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cel... by Airi Fujimoto, Yoshimichi Koutake, Daisuke Hisamatsu, Noriko Ookubo, Yurika Yabuuchi, Go Kamimura, Tatsuo Kai, Aki Kozono, Takahiro Ootsu, Hiroto Suzuki, Keisuke Matsuo, Kimiko Kuwahara, Yoshita Oiwane, Yuko Nagata, Kenya Tanimoto, Eri Sato, Mei Suenaga, Tomohiro Uehara, Akira Ikari, Satoshi Endo, Yoichi Hiraki, Yosei Kawamata

    Published 2024-12-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 44
    HDAC1-3 inhibition triggers NEDD4-mediated CCR2 downregulation and attenuates immunosuppression in myeloid-derived suppressor cells

    HDAC1-3 inhibition triggers NEDD4-mediated CCR2 downregulation and attenuates immunosuppression in myeloid-derived suppressor cells by Zhiqi Xie, Jinjin Shao, Zeren Shen, Zhichao Ye, Yoshiaki Okada, Daisuke Okuzaki, Naoki Okada, Masashi Tachibana

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 45
    New insights into the immunomodulatory potential of sialic acid on monocyte-derived dendritic cells

    New insights into the immunomodulatory potential of sialic acid on monocyte-derived dendritic cells by Zélia Silva, João Amorim Rabaça, Vanessa Luz, Rita Adubeiro Lourenço, Mariolina Salio, Alexandra Couto Oliveira, Pedro Bule, Sebastian Springer, Paula Alexandra Videira

    Published 2024-11-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 46
    A comprehensive analysis of molecular characteristics of hot and cold tumor of gastric cancer

    A comprehensive analysis of molecular characteristics of hot and cold tumor of gastric cancer by Chenxi Lv, Tianwei Chen, Jiangtao Li, Yuqiang Shan, Hong Zhou

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 47
    Elevated SAMD3 expression in T cells predicts improved survival in pancreatic ductal adenocarcinoma patients

    Elevated SAMD3 expression in T cells predicts improved survival in pancreatic ductal adenocarcinoma patients by Lingyi Fu, Enliang Zhou, Shuo Li, Ziteng Li, Liyan Wu, Xinxin Zhou, Lang Tian, Bokang Cui

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 48
    KMO-driven metabolic reconfiguration and its impact on immune cell infiltration in nasopharyngeal carcinoma: a new avenue for immunotherapy

    KMO-driven metabolic reconfiguration and its impact on immune cell infiltration in nasopharyngeal carcinoma: a new avenue for immunotherapy by Nijun Chen, Yuan Zong, Chen Yang, Lei Li, Yang Yi, Jiawen Zhao, Xiaoyu Zhao, Xianfei Xie, Xingmei Sun, Ning Li, Liting Jiang

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 49
    Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer

    Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer by Cecilia Olsson Ladjevardi, Marcus Skribek, Anthoula Koliadi, Viktoria Rydén, Ali Inan El-Naggar, Evangelos Digkas, Antonios Valachis, Gustav J. Ullenhag

    Published 2024-11-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 50
    Interdependence of coagulation with immunotherapy and BRAF/MEK inhibitor therapy: results from a prospective study

    Interdependence of coagulation with immunotherapy and BRAF/MEK inhibitor therapy: results from a prospective study by Malte Beckmann, Julian Schlüter, Michael Erdmann, Rafaela Kramer, Sarah Cunningham, Holger Hackstein, Robert Zimmermann, Lucie Heinzerling

    Published 2024-11-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 51
    Artificial neural network systems to predict the response to sintilimab in squamous-cell non-small-cell lung cancer based on data of ORIENT-3 study

    Artificial neural network systems to predict the response to sintilimab in squamous-cell non-small-cell lung cancer based on data of ORIENT-3 study by Tongji Xie, Guangyu Fan, Le Tang, Puyuan Xing, Yuankai Shi

    Published 2024-12-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 52
    SUMO modified ETV1 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by facilitating CCL2 transcription in esophageal squamous cell carcinoma cells

    SUMO modified ETV1 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by facilitating CCL2 transcription in esophageal squamous cell carcinoma ce... by Tianci Han, Xiaoqi Guo, Junwei Xie, Wei Tong, Liang Zhang

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 53
    Antitumor effects of natural killer cells derived from gene-engineered human-induced pluripotent stem cells on hepatocellular carcinoma

    Antitumor effects of natural killer cells derived from gene-engineered human-induced pluripotent stem cells on hepatocellular carcinoma by Mayuna Nakamura, Yuka Tanaka, Keishi Hakoda, Masahiro Ohira, Tsuyoshi Kobayashi, Kenji Kurachi, Kouichi Tamura, Hideki Ohdan

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 54
    Periodontitis promotes tumor growth and immune evasion via PD-1/PD-L1

    Periodontitis promotes tumor growth and immune evasion via PD-1/PD-L1 by Suli Wang, Fujiao Nie, Qiuyue Yin, Haoyang Tian, Pizhang Gong, Jinhong Ju, Jiayi Liu, Pishan Yang, Chengzhe Yang

    Published 2024-11-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 55
    Pre-injection of exosomes can significantly suppress ovarian cancer growth by activating the immune system in mice

    Pre-injection of exosomes can significantly suppress ovarian cancer growth by activating the immune system in mice by Yuanyuan Wang, Changyi Zhang, Huimin Zeng, Liangliang Wang, Zanhong Wang, Zhiqiang Han

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 56
    Targeting OAS3 for reversing M2d infiltration and restoring anti-tumor immunity in pancreatic cancer

    Targeting OAS3 for reversing M2d infiltration and restoring anti-tumor immunity in pancreatic cancer by Shaopeng Zhang, Ximo Xu, Kundong Zhang, Changzheng Lei, Yitian Xu, Pengshan Zhang, Yuan Zhang, Haitao Gu, Chen Huang, Zhengjun Qiu

    Published 2024-12-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 57
    Pre-immunotherapy alters stereotactic ablative radiotherapy-induced systemic T cell responses in early-stage NSCLC

    Pre-immunotherapy alters stereotactic ablative radiotherapy-induced systemic T cell responses in early-stage NSCLC by Chao Liu, Yanjuan Chen, Xiaohui Li, Zhijie Bai, Meilin Jiang, Dongsheng Sheng, Wenxue Zou, Rui Huang, Qingyu Huang, Fuhao Wang, Jingyang Zhu, Huiru Sun, Bing Liu, Zongcheng Li, Bing Sun

    Published 2025-02-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 58
    Dendritic cell maturation is induced by p53-armed oncolytic adenovirus via tumor-derived exosomes enhancing systemic antitumor immunity

    Dendritic cell maturation is induced by p53-armed oncolytic adenovirus via tumor-derived exosomes enhancing systemic antitumor immunity by Tomoko Ohtani, Shinji Kuroda, Nobuhiko Kanaya, Yoshihiko Kakiuchi, Kento Kumon, Masashi Hashimoto, Chiaki Yagi, Ryoma Sugimoto, Satoru Kikuchi, Shunsuke Kagawa, Hiroshi Tazawa, Yasuo Urata, Toshiyoshi Fujiwara

    Published 2024-11-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 59
    Breaking the shield of solid tumors: a combined approach for enhanced efficacy of CAR-T cells

    Breaking the shield of solid tumors: a combined approach for enhanced efficacy of CAR-T cells by Marat Khaliulin, Aygul Valiullina, Alexey Petukhov, Youyong Yuan, Sheila Spada, Emil Bulatov

    Published 2024-11-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 60
    Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study

    Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study by Lingzhan Meng, Hu Li, Yingjie Ji, Peng Yu, Zizheng Wang, Li Cao, Bin Shi, Yanling Shao, Jin Yan, Yinjie Gao, Zhenyu Zhu

    Published 2024-11-01
    “…Cancer Immunology, Immunotherapy…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: